ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri

[1]  Manesh R. Patel,et al.  Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force. , 2013, Journal of the American College of Cardiology.

[2]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[3]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[4]  R. Fimmers,et al.  Kidney Dysfunction and Deterioration of Ejection Fraction Pose Independent Risk Factors for Mortality in Implantable Cardioverter‐Defibrillator Recipients for Primary Prevention , 2012, Clinical cardiology.

[5]  Niraj Varma,et al.  Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration. , 2012, Journal of the American College of Cardiology.

[6]  A. Russo,et al.  HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons. , 2012, Heart rhythm.

[7]  Wojciech Zareba,et al.  Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. , 2012, Journal of the American College of Cardiology.

[8]  L. Wann,et al.  ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thor , 2012, Journal of the American College of Cardiology.

[9]  J. Curtis,et al.  Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. , 2012, Archives of internal medicine.

[10]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.

[11]  R. Lazzara,et al.  The Benefit of Cardiac Resynchronization Therapy and QRS Duration: A Meta‐Analysis , 2012, Journal of cardiovascular electrophysiology.

[12]  P. Zimetbaum,et al.  Time for a change--a new approach to ICD replacement. , 2012, The New England journal of medicine.

[13]  D. Hodge,et al.  Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. , 2012, Heart rhythm.

[14]  H. Halperin,et al.  End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants , 2011, Journal of cardiovascular electrophysiology.

[15]  W. Winkelmayer,et al.  Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  G. Marcus,et al.  Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. , 2011, Journal of the American College of Cardiology.

[17]  D. Simon,et al.  Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials , 2011 .

[18]  A. Ha,et al.  Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review. , 2011, Heart rhythm.

[19]  Warren J Manning,et al.  ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, , 2011, Journal of the American College of Cardiology.

[20]  A. Moss,et al.  Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. , 2011, Heart rhythm.

[21]  H. Katus,et al.  Troponin elevation in coronary vs. non-coronary disease. , 2011, European heart journal.

[22]  M. Gold.  Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry , 2011 .

[23]  R. Brindis.  President's page: cardiovascular professionals: are we knights in shining armor or just knaves and pawns? , 2010, Journal of the American College of Cardiology.

[24]  I. Piña,et al.  Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. , 2010, Heart rhythm.

[25]  Eugene Crystal,et al.  Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. , 2010, Journal of the American College of Cardiology.

[26]  Ó. Cano,et al.  Defibrillator implantation early after myocardial infarction. , 2010, The New England journal of medicine.

[27]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[28]  C. O'connor,et al.  Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. , 2009, Heart rhythm.

[29]  S. Shkurovich,et al.  Implantable cardioverter-defibrillator prescription in the elderly. , 2009, Heart rhythm.

[30]  D. Berman,et al.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Associa , 2009, Journal of the American College of Cardiology.

[31]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[32]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[33]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[34]  L. Jordaens,et al.  Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. , 2008, International journal of cardiology.

[35]  J. Conti,et al.  Task force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management endorsed by the Heart Rhythm Society. , 2008, Journal of the American College of Cardiology.

[36]  P. Tchou,et al.  Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. , 2007, The New England journal of medicine.

[37]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[38]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[39]  Peter C Austin,et al.  Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. , 2007, Journal of the American College of Cardiology.

[40]  B. Lindsay,et al.  Poor Prognosis for Patients with Chronic Kidney Disease Despite ICD Therapy for the Primary Prevention of Sudden Death , 2007, Pacing and clinical electrophysiology : PACE.

[41]  E. Maltezos,et al.  Could sustained monomorphic ventricular tachycardia in the early phase of a prime acute myocardial infarction affect patient outcome? , 2007, Journal of electrocardiology.

[42]  W. B. Fye.  Troponin trumps common sense. , 2006, Journal of the American College of Cardiology.

[43]  I. V. Van Gelder,et al.  Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients. , 2006, Heart rhythm.

[44]  A. Moss,et al.  Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. , 2006, The American journal of cardiology.

[45]  R. Hendel,et al.  ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. , 2005, Journal of the American College of Cardiology.

[46]  Arjun D. Sharma,et al.  Percent right ventricular pacing predicts outcomes in the DAVID trial. , 2005, Heart rhythm.

[47]  Paul J. Wang,et al.  The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II , 2005, Journal of cardiovascular electrophysiology.

[48]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[49]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[50]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[51]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[52]  M. Josephson,et al.  Prognostic Significance of Nonsustained Ventricular Tachycardia Identified Postoperatively After Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction , 2002, Journal of cardiovascular electrophysiology.

[53]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[54]  B. Burnand,et al.  The RAND/UCLA Appropriateness Method User's Manual , 2001 .

[55]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[56]  L. Mont,et al.  Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. , 1996, Journal of the American College of Cardiology.

[57]  G. Hindricks,et al.  Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. , 1994, European heart journal.